Epstein–Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte Glycoprotein‐Antibody‐Associated Disease
Annals of Neurology · 2024-04 · 95 (4) · 700-705
DOI: 10.1002/ana.26890 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 27.02.2024. Verfasst von Giulia Fadda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Multiple Sclerosis. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Canadian Multiple Sclerosis Scientific Research Foundation.
Abstract (Originalsprache)
Reported rates of Epstein–Barr virus (EBV) seropositivity in children meeting multiple sclerosis (MS) diagnostic criteria are considerably lower than those reported in adult‐onset MS, putting in question a requisite role for EBV in MS development. As prior work preceded recognition of myelin oligodendrocyte glycoprotein‐associated disease (MOGAD), we assessed viral serologies in 251 children with incident demyelination and prospectively ascertained diagnoses. When MOGAD was serologically accounted for, the prevalence of EBV infection among MS children exceeded 90%, whereas remote EBV infection was not associated with MOGAD risk. Together, these findings substantiate EBV's role across the MS spectrum, and support distinct pathobiological mechanisms in MS versus MOGAD. ANN NEUROL 2024;95:700–705
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
- The Hospital for Sick Children, Toronto, ON, Canada.
- Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH.
- Nuffield Department of Clinical Neuroscience, John Redcliffe Hospital, University of Oxford, Oxford, United Kingdom.
- Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Science, University of Manitoba, Winnipeg, MB, Canada.
- Montreal Neurological Institute, Montreal, QC, Canada.
ORCID-Profile: Giulia Fadda, Douglas Arnold
Förderung
- Canadian Multiple Sclerosis Scientific Research Foundation
Zitieren
APA
Fadda, G., Yea, C., O'Mahony, J., Waters, P., Yeh, E. A., Marrie, R. A., Arnold, D., Bar-Or, A., Banwell, B., & Canadian Pediatric Demyelinating Disease Study Group (2024). Epstein–Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte Glycoprotein‐Antibody‐Associated Disease. Annals of Neurology, 95(4), 700-705. https://doi.org/10.1002/ana.26890
Vancouver
Fadda G, Yea C, O'Mahony J, Waters P, Yeh EA, Marrie RA, et al. Epstein–Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte Glycoprotein‐Antibody‐Associated Disease. Annals of Neurology. 2024;95(4):700-705. doi:10.1002/ana.26890
BibTeX
@article{Fadda2024,
author = {Fadda, Giulia and Yea, Carmen and O'Mahony, Julia and Waters, Patrick and Yeh, E Ann and Marrie, Ruth Ann and Arnold, Douglas and Bar-Or, Amit and Banwell, Brenda and Canadian Pediatric Demyelinating Disease Study Group, Canadian Pediatric Demyelinating Disease Study Group},
title = {Epstein–Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte Glycoprotein‐Antibody‐Associated Disease},
journal = {Annals of Neurology},
year = {2024},
volume = {95},
number = {4},
pages = {700--705},
doi = {10.1002/ana.26890}
}
EUVIMED